882679-23-4 Usage
Uses
Used in Chemical Synthesis:
2-amino-3-iodo-4-methylbenzoic acid is used as a building block for the synthesis of a wide range of other chemicals. Its functional groups and active benzene ring structure make it a versatile compound in the creation of various chemical products.
Used in Organic Reactions:
2-amino-3-iodo-4-methylbenzoic acid is used as an intermediary reagent in various organic reactions. Its unique structure allows it to participate in a variety of chemical transformations, contributing to the development of new compounds and materials.
Used in Research Applications:
2-amino-3-iodo-4-methylbenzoic acid is used as a research compound for studying its properties and potential applications in various fields. Its synthesis and reactivity are of interest to chemists and researchers working on the development of new chemical processes and products.
Check Digit Verification of cas no
The CAS Registry Mumber 882679-23-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,6,7 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 882679-23:
(8*8)+(7*8)+(6*2)+(5*6)+(4*7)+(3*9)+(2*2)+(1*3)=224
224 % 10 = 4
So 882679-23-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H8INO2/c1-4-2-3-5(8(11)12)7(10)6(4)9/h2-3H,10H2,1H3,(H,11,12)
882679-23-4Relevant academic research and scientific papers
NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS AND METHODS OF USE
-
Page/Page column 72, (2008/06/13)
The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have Formula (I) wherein R1 is Formula (II), (III) or (IV) and A1, A2, A3, A4, X, Z, Z', R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
